Prevention of early vitamin K deficiency bleeding (VKDB) of the newborn, with onset at birth to 2 weeks of age (formerly known as classic hemorrhagic disease of the newborn), by oral or parenteral administration of vitamin K is accepted practice. In contrast, late VKDB, with onset from 2 to 12 weeks of age, is most effectively prevented by parenteral administration of vitamin K. Earlier concern regarding a possible causal association between parenteral vitamin K and childhood cancer has not been substantiated. This revised statement presents updated recommendations for the use of vitamin K in the prevention of early and late VKDB.
Subjects:
Agency ABCs
Copyright © 2003 by the American Academy of Pediatrics
2003
You do not currently have access to this content.
The research I am reading seems to support oral vitamin K as effective as intramuscular. This article seems to imply that the oral dosing may not be as effective however in breastfed infants. Is there research that was found that displays that evidence? And if not, are steps being taken to change the guidelines to include oral dosing in the vitamin K protocol?